Johnson & Johnson's first-quarter profit beat estimates as the health giant's drug sales came in higher than Wall Street analysts expected. Read this story
Johnson & Johnson's first-quarter profit beat estimates as the health giant's drug sales came in higher than Wall Street analysts expected. Read this story
More from Bloomberg | JOHNSON & JOHNSON Wall Street KENVUE INC Drugs Investing SHOCKWAVE MEDICAL INC Retail Industrials Healthcare Americas industries Johnson & Johnson Earnings NYSE:JNJ